Ishares Msci Brazil ETF vs Herbalife Nutrition Ltd — how do they compare? Ishares Msci Brazil ETF trades at $43.54 (market cap $11.30B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Ishares Msci Brazil ETF is far larger — about 8.4× Herbalife Nutrition Ltd's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EWZ | HLF | |
|---|---|---|
Market Cap | $11.30B | $1.34B |
Volume | 44,036,597 | 1,589,457 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $43.00 | $19.96 |
52-Week Low | $28.79 | $7.75 |
Typical Hold Time | 50 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $42.59, up 0.52% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF is heavily influenced by Brazil's upcoming October 2026 election, with institutional investors accumulating call options betting on a favorable outcome. Recent news highlights EWZ as a diversifier from U.S. tech exposure, though it faces competition from lower-fee alternatives like FLBR.
The outlook for EWZ hinges on Brazil's election result and commodity trends, offering asymmetric upside if pro-market policies prevail. Key risks include political volatility, U.S. tariff impacts, and currency fluctuations. Wall Street sentiment is cautiously optimistic, with unusual options activity signaling speculative interest in near-term gains.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →